Flavonoids in the Amelioration of Hypertiglyceridemia
Flavonoids in the Amelioration of Hypertiglyceridemia
批准号:
6787622
负责人:
ANDRE G THERIAULT
金额:
$17.04万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2007-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long term goal of this research project is to examine the influence of complementary and alternative medicine (CAM) bioflavonoid-rich extracts (i.e. green tea leaf extracts, citrus bioflavonoids, and rutin) on the regulation of hepatic triglyceride-rich lipoprotein production in a hypertriglyceridemic model. Bioflavonoid-rich extracts have been claimed to protect against cardiovascular disease (CVD), in large part through its inhibitory effect on low density lipoprotein (LDL) oxidation. The potential benefit of these compounds in treating hyperlipidemia has also recently been shown in both animal and human studies. However, the molecular mechanisms for this lipid-lowering action are not fully understood. We have recently shown that a citrus bioflavonoid administered to hypertriglyceridemic-insulin resistant (HIR) hamsters lowered blood triglyceride levels through the inhibition of hepatic microsomal triglyceride transfer protein (MTP) protein expression and diacylglycerol acyltransferase (DGAT) activity. These results are preliminary and need to be confirmed on a larger scale. Nonetheless, these results do unveil a potentially exciting area of research. The role of other lipogenic enzymes in VLDL production needs to be explored. Also, whether or not the assembly and secretion of hepatic apoB100-VLDL is altered need to be addressed. Moreover, it is not known if all bioflavonoids possess a triglyceride-lowering ability. Therefore, the specific aim of this study using both plasma and isolated hepatocytes is to investigate the effect of bioflavonoid-rich extracts on the in vivo and ex vivo VLDL production in HIR hamsters. This will be done by measuring the rate in VLDL secretion in plasma, and by using isolated hepatocytes, the synthesis and secretion of apoB-100 and triglyceride, and lipogenic enzyme expression and activity. By understanding the lipid lowering function of these products, we aimed at providing new information of these commonly used CAM products.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Cruciferous indole-3-carbinol inhibits apolipoprotein B secretion in HepG2 cells.
十字花科 indole-3-carbinol 抑制 HepG2 细胞中载脂蛋白 B 的分泌。
DOI:
10.1093/jn/137.10.2185
发表时间:
2007
期刊:
The Journal of nutrition
影响因子:
--
作者:
[Maiyoh,GeoffreyK, Kuh,JoanE, Casaschi,Adele, Theriault,AndreG]
通讯作者:
Theriault,AndreG
Cruciferous Indoles in the Amelioration of the Metabolic Syndrome
-
批准号:7313449
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:ANDRE G THERIAULT
-
依托单位:
EFFECTS OF PLANT FLAVONOID ON GLUCOSE AND LIPID METABOLI
-
批准号:6972103
-
项目类别:
-
资助金额:$0.42万
-
财政年份:2004
-
负责人:ANDRE G THERIAULT
-
依托单位:
Flavonoids in the Amelioration of Hypertiglyceridemia
-
批准号:6679735
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2003
-
负责人:ANDRE G THERIAULT
-
依托单位:
海外基金